 |
市場調查報告書
商品編碼
1629605
二尖瓣疾病市場：依治療類型、適應症、依設備類型、依最終使用者、按地區Mitral Valve Disease Market, By Treatment Type, By Indication, By Device Type, By End User, By Geography |
||||||
預計2024年全球二尖瓣疾病市場規模為28億美元，預計2031年將達51.2億美元，2024年至2031年複合年成長率為9%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 28億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 預測 2024-2031 年複合年成長率： | 9.00% | 2031年價值預測 | 51.2億美元 |
二尖瓣疾病是指影響位於心臟左心房和左心室之間的二尖瓣的疾病。二尖瓣在調節從左心房到左心室的血流中扮演重要角色。二尖瓣疾病的常見類型包括二尖瓣狹窄（導致二尖瓣狹窄或阻塞）和二尖瓣瓣膜閉鎖不全（導致血液通過二尖瓣逆流）。老齡化、風濕熱、先天性心臟疾病、感染疾病等因素都會傷害二尖瓣並引發疾病。目前尚無治癒二尖瓣疾病的治療方法，但治療的目的是透過二尖瓣修復或置換術等手術來修復或更換受損的二尖瓣。
市場動態
全球二尖瓣疾病市場是由全球老年人口的成長所推動的，由於老齡化相關的心臟瓣膜退化，老年人口更容易患二尖瓣疾病。開發中國家風濕性心臟疾病盛行率的增加可能會推動預測期內的市場成長。然而，二尖瓣修復和置換手術的高成本以及缺乏熟練的醫療保健專業人員可能會阻礙市場成長。隨著新的二尖瓣修復技術和技術的不斷開發，市場參與者存在有利的成長機會。
本研究的主要特點
該報告對全球二尖瓣疾病市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
根據公司亮點、產品系列、主要亮點、績效和策略等參數，對全球二尖瓣疾病市場的主要企業進行概況分析。
主要公司包括 Edwards Lifesciences Corporation、Medtronic Plc、Abbott Laboratories、Boston Scientific Corporation、Corcym UK Limited、Artivion, Inc.、ShockWave Medical, Inc.、Valcare Medical、Braile Biomedica、Labcor Laboratorios Ltda、Zydus Lifesciences Limited、Affluence Medicalence 、Tevacor製藥工業有限公司、拜耳公司和諾華公司。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球二尖瓣疾病市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球二尖瓣疾病市場的各種策略矩陣，促進相關人員的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 主要進展
- 監管場景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
- 產業動態
第4章全球二尖瓣疾病市場，依治療類型，2019-2031
- 二尖瓣修復術
- 二尖瓣置換術術
- 心臟再同步治療（CRT）
- 二尖瓣治療
第5章全球二尖瓣疾病市場，依適應症分類，2019-2031
- 瓣膜閉鎖不全
- 二尖瓣狹窄
- 二尖瓣脫垂
第6章全球二尖瓣疾病市場，依設備類型，2019-2031
- 手術器械
- 植入裝置
- 診斷設備
第 7 章 全球二尖瓣疾病市場，依最終使用者分類，2019-2031 年
- 醫院
- 門診手術中心
- 專科診所
- 心臟復健中心
- 其他
第8章全球二尖瓣疾病市場（按地區），2019-2031
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第9章 競爭格局
- Edwards Lifesciences Corporation
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corporation
- Corcym UK Limited
- Artivion, Inc.
- ShockWave Medical, Inc.
- Valcare Medical
- Braile Biomedica
- Labcor Laboratorios Ltda
- Zydus Lifesciences Limited
- Affluent Medical
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Novartis AG
第10章分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第11章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
Global mitral valve disease market is estimated to be valued at USD 2.80 Bn in 2024 and is expected to reach USD 5.12 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 2.80 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 9.00% | 2031 Value Projection: | US$ 5.12 Bn |
Mitral valve disease refers to conditions that affect the mitral valve located between the left atrium and left ventricle of the heart. Mitral valve plays a key role in regulating blood flow from the left atrium to the left ventricle. Some common types of mitral valve disease include mitral valve stenosis, which causes narrowing or blockage of the mitral valve, and mitral valve regurgitation or insufficiency, which allows blood to flow backward through the mitral valve. Factors such as aging, rheumatic fever, congenital heart defects, and infections can damage the mitral valve and lead to diseases. Presently, there is no cure for mitral valve disease, however, treatments aim to repair or replace the damaged mitral valve via procedures such as mitral valve repair or replacement surgeries.
Market Dynamics
Global mitral valve disease market growth is driven by rising geriatric population globally who are more prone to develop mitral valve diseases due to age-related degeneration of heart valves. Increasing prevalence of rheumatic heart disease in developing nations can drive the market growth during the forecast period. However, high costs associated with mitral valve repair and replacement surgeries along with lack of skilled healthcare professionals can hamper the market growth. Ongoing development of novel mitral valve repair technologies and techniques present lucrative growth opportunities for market players.
Key Features of the Study
This report provides in-depth analysis of the global mitral valve disease market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global mitral valve disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Corcym UK Limited, Artivion, Inc., ShockWave Medical, Inc., Valcare Medical, Braile Biomedica, Labcor Laboratorios Ltda, Zydus Lifesciences Limited, Affluent Medical, Teva Pharmaceutical Industries Ltd., Bayer AG, and Novartis AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global mitral valve disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mitral valve disease market
Market Segmentation
- Treatment Type Insights (Revenue, USD Bn, 2019 - 2031)
- Mitral Valve Repair
- Surgical Mitral Valve Repair
- Transcatheter Mitral Valve Repair
- Mitral Valve Replacement
- Mechanical Valve Replacement
- Biological Valve Replacement
- Transcatheter Aortic Valve Replacement (TAVR)
- Cardiac Resynchronization Therapy (CRT)
- Biventricular Pacing
- Implantable Cardioverter Defibrillators (ICDs)
- Mitral Valve Therapeutics
- Pharmacological Treatments
- Device-Based Therapies
- Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Mitral Valve Regurgitation
- Mitral Valve Stenosis
- Mitral Valve Prolapse
- Device Type Insights (Revenue, USD Bn, 2019 - 2031)
- Surgical Instruments
- Heart-Lung Machines
- Surgical Staplers
- Sutures
- Implant Devices
- Mitral Valve Prostheses
- Repair Devices (e.g., annuloplasty rings)
- Diagnostic Devices
- Echocardiograms
- Cardiac Imaging Systems
- End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Cardiac Rehabilitation Centers
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Key Players Insights
- Edwards Lifesciences Corporation
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corporation
- Corcym UK Limited
- Artivion, Inc.
- ShockWave Medical, Inc.
- Valcare Medical
- Braile Biomedica
- Labcor Laboratorios Ltda
- Zydus Lifesciences Limited
- Affluent Medical
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Novartis AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Mitral Valve Disease Market, By Treatment Type
- Global Mitral Valve Disease Market, By Indication
- Global Mitral Valve Disease Market, By Device Type
- Global Mitral Valve Disease Market, By End User
- Global Mitral Valve Disease Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Mitral Valve Disease Market, By Treatment Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Mitral Valve Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Surgical Mitral Valve Repair
- Transcatheter Mitral Valve Repair
- Mitral Valve Replacement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mechanical Valve Replacement
- Biological Valve Replacement
- Transcatheter Aortic Valve Replacement (TAVR)
- Cardiac Resynchronization Therapy (CRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Biventricular Pacing
- Implantable Cardioverter Defibrillators (ICDs)
- Mitral Valve Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Pharmacological Treatments
- Device-Based Therapies
5. Global Mitral Valve Disease Market, By Indication, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Mitral Valve Regurgitation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mitral Valve Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mitral Valve Prolapse
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Mitral Valve Disease Market, By Device Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Surgical Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Heart-Lung Machines
- Surgical Staplers
- Sutures
- Implant Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mitral Valve Prostheses
- Repair Devices (e.g., annuloplasty rings)
- Diagnostic Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Echocardiograms
- Cardiac Imaging Systems
7. Global Mitral Valve Disease Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cardiac Rehabilitation Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Mitral Valve Disease Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Edwards Lifesciences Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Corcym UK Limited
- Artivion, Inc.
- ShockWave Medical, Inc.
- Valcare Medical
- Braile Biomedica
- Labcor Laboratorios Ltda
- Zydus Lifesciences Limited
- Affluent Medical
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Novartis AG
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
